Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa
Clinical trial NCT00866619 · COMPLETED
Trial details
- NCT number
- NCT00866619
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-27
- Primary completion
- 2011-03-01
- Enrollment
- 15459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.